Biotts

Biotts

Verified
Developing pharmaceutical technology and drug formulas in the field of oncology, dermatology, and autoimmune diseases.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
€6—10m (Dealroom.co estimates May 2020.)
Company register number KRS0000738948
Wroclaw Lower Silesian Voivodeship (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR201820192020202120222023
Revenues<1m<1m<1m<1m<1m<1m
% growth-(82 %)581 %(58 %)-26 %
EBITDA(<1m)<1m(<1m)(<1m)--
% EBITDA margin(32 %)6 %(686 %)(2037 %)--
Profit(<1m)(<1m)(<1m)(<1m)--
% profit margin(39 %)(248 %)(766 %)(2376 %)--
  • Edit
DateInvestorsAmountRound
-

N/A

-
*

PLN7.0m

Seed
*

N/A

-
Total Funding€1.6m

Recent News about Biotts

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.